Provided by Tiger Fintech (Singapore) Pte. Ltd.

CSPC PHARMA

4.860
+0.0901.89%
Volume:67.70M
Turnover:327.34M
Market Cap:56.10B
PE:9.16
High:4.870
Open:4.820
Low:4.790
Close:4.770
Loading ...

Voluntary Announcement - Leuprorelin Extended-Release Injection (Syh9016) Obtains Clinical Trial Approval

THOMSON REUTERS
·
30 Dec 2024

CSPC Pharmaceutical - Clinical Trial Approval Granted by Nmpa of China

THOMSON REUTERS
·
30 Dec 2024

BRIEF-CSPC Pharmaceutical Says SYH2062 Injection Approved To Conduct Clinical Trials In China

Reuters
·
23 Dec 2024

CSPC Pharmaceutical - Syh2062 Injection Approved by Nmpa to Conduct Clinical Trials in China

THOMSON REUTERS
·
23 Dec 2024

CSPC Pharmaceutical Gets Clinical Trial Go-Ahead for Tumor Drug in China

MT Newswires Live
·
20 Dec 2024

CSPC Pharmaceutical Gets China Nod for Clinical Trial of Cancer Drug

MT Newswires Live
·
20 Dec 2024

CSPC Pharmaceutical Says Semaglutide Long-Acting Injection Obtains Clinical Trial Approval

Reuters
·
20 Dec 2024

BRIEF-CSPC Pharmaceutical Obtains Clinical Trial Approval For SYS6043 (Antibody-Drug Conjugate) From NMPA

Reuters
·
20 Dec 2024

CSPC Pharmaceutical - Sys6005 (Antibody-Drug Conjugate) Obtains Clinical Trial Approval From Nmpa

THOMSON REUTERS
·
20 Dec 2024

CSPC Pharmaceutical - Approval Granted by China's Nmpa

THOMSON REUTERS
·
20 Dec 2024

CSPC Pharmaceutical - Semaglutide Long-Acting Injection (Syh9017) Obtains Clinical Trial Approval

THOMSON REUTERS
·
20 Dec 2024

CSPC Pharmaceutical Group Grants Exclusive License of Cancer Inhibitor to BeiGene Switzerland

MT Newswires Live
·
13 Dec 2024

BRIEF-CSPC Pharmaceutical Announces Exclusive License Agreement For SYH2039 With Beigene

Reuters
·
13 Dec 2024

CSPC Pharmaceutical - Exclusive License Agreement for Syh2039 With Beigene

THOMSON REUTERS
·
13 Dec 2024

China Healthcare Sector's Recovery Momentum May Continue in 2025 -- Market Talk

Dow Jones
·
10 Dec 2024

CSPC Pharmaceutical Unit Gets Chinese Drug Regulator's Marketing Approval for Breast Cancer Drug

MT Newswires Live
·
09 Dec 2024